Revolution Stalled
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Drug discovery is at a near standstill for psychiatric disorders such as schizophrenia, bipolar disorder, and depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Self-citationOptogenetics in neural systems
Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M., & Deisseroth, K. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.004 · Cited by 1,881
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Genetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Research works printed but not linked: 4
- E. J. Nestler S. E. Hyman R. J. Malenka Molecular Neuropharmacology: Foundation for Clinical Neuroscience (McGraw Hill New York 2009).
- National Center for Biotechnology Information of the US National Library of Medicine www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed. Consulted 25 August 2012.
- T. S. Kuhn The Structure of Scientific Revolutions (Univ. Chicago Press Chicago ed. 2 1962).
- D. J. Carlat Unhinged: The Trouble with Psychiatry (Free Press New York 2010).
Cited by
Rare coding variants in ten genes confer substantial risk for schizophrenia
Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., et al. (2022) · Nature · doi:10.1038/s41586-022-04556-w · Cited by 983
Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers
Clementz, B. A., Sweeney, J. A., Hamm, J. P., Ivleva, E. I., Ethridge, L. E., Pearlson, G. D., Keshavan, M. S., & Tamminga, C. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14091200 · Cited by 768
Prefrontal cortex and depression
Pizzagalli, D. A., & Roberts, A. C. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01101-7 · Cited by 667
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
The promises and challenges of human brain organoids as models of neuropsychiatric disease
Quadrato, G., Brown, J., & Arlotta, P. (2016) · Nature Medicine · doi:10.1038/nm.4214 · Cited by 304
Rediscovering Psychopathology: The Epistemology and Phenomenology of the Psychiatric Object
Parnas, J., Sass, L. A., & Zahavi, D. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs153 · Cited by 257
Animal models of PTSD: a challenge to be met
Richter-Levin, G., Stork, O., & Schmidt, M. V. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0272-5 · Cited by 218
The road to precision psychiatry: translating genetics into disease mechanisms
Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4409 · Cited by 223
Psychedelics: Where we are now, why we got here, what we must do
Belouin, S. J., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.018 · Cited by 187
Improving and Accelerating Drug Development for Nervous System Disorders
Pankevich, D. E., Altevogt, B. M., Dunlop, J., Gage, F. H., & Hyman, S. E. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.007 · Cited by 206
Self-citationWiecki, T. V., Poland, J., & Frank, M. J. (2015) · Clinical Psychological Science · doi:10.1177/2167702614565359 · Cited by 182
Putting the “mental” back in “mental disorders”: a perspective from research on fear and anxiety
Taschereau-Dumouchel, V., Michel, M., Lau, H., Hofmann, S. G., & LeDoux, J. E. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01395-5 · Cited by 186
The Scientific Case for Brain Simulations
Einevoll, G. T., Destexhe, A., Diesmann, M., Grün, S., Jirsa, V., de Kamps, M., Migliore, M., Ness, T. V., Plesser, H. E., & Schürmann, F. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.027 · Cited by 190
Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives
Amadio, J., Bi, G.-Q., Boshears, P. F., Carter, A., Devor, A., Doya, K., Garden, H., Illes, J., Johnson, L. S. M., Jorgenson, L., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.021 · Cited by 166
Pike, A. C., & Robinson, O. J. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0051 · Cited by 167
Don’t stress about CRF: assessing the translational failures of CRF1antagonists
Spierling, S. R., & Zorrilla, E. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4556-2 · Cited by 170
The NIMH experimental medicine initiative
Insel, T. R. (2015) · World Psychiatry · doi:10.1002/wps.20227 · Cited by 165
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155
Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds
Bruni, G. N., Rennekamp, A. J., Velenich, A., McCarroll, M. N., Gendelev, L., Fertsch, E., Taylor, J. C., Lakhani, P., Lensen, D., Evron, T., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2097 · Cited by 164
Singh, T., Neale, B. M., & Daly, M. J. (2020) · doi:10.1101/2020.09.18.20192815 · Cited by 980
“SETD1A encodes a catalytic subunit of the COMPASS histone methyltransferase complex that performs mono-, di-, and tri-methylation at Histone H3 Lysine 4.”
BackgroundOpportunities and challenges in modeling human brain disorders in transgenic primates
Jennings, C. G. B., Landman, R., Zhou, Y., Sharma, J., Hyman, J. B., Movshon, J. A., Qiu, Z., Roberts, A., Roe, A. W., Wang, X., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4362 · Cited by 151
Global research priorities for youth mental health
Mei, C., Fitzsimons, J., Allen, N., Alvarez‐Jimenez, M., Amminger, G. P., Browne, V., Cannon, M., Davis, M., Dooley, B., Hickie, I. B., et al. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.12878 · Cited by 117
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium
Clementz, B. A., Parker, D., Trotti, R. L., McDowell, J. E., Keedy, S., Keshavan, M. S., Pearlson, G. D., Gershon, E. S., Ivleva, E. I., Huang, L.-Y., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab090 · Cited by 135
Neurofeedback and networks of depression
Linden, D. E. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/dlinden · Cited by 125
Translational assessment of reward and motivational deficits in psychiatric disorders
Der-Avakian, A., Barnes, S. A., Markou, A., & Pizzagalli, D. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5004 · Cited by 122
Wallis, C. U., Cardinal, R. N., Alexander, L., Roberts, A. C., & Clarke, H. F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620115114 · Cited by 117
New paradigms for treatment‐resistant depression
Zarate, C., Duman, R. S., Liu, G., Sartori, S., Quiroz, J., & Murck, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12223 · Cited by 109
Ting, J. T., Kalmbach, B., Chong, P., de Frates, R., Keene, C. D., Gwinn, R. P., Cobbs, C., Ko, A. L., Ojemann, J. G., Ellenbogen, R. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26803-9 · Cited by 116
BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders
Schubert, C. R., O’Donnell, P., Quan, J., Wendland, J. R., Xi, H. S., Winslow, A. R., Domenici, E., Essioux, L., Kam-Thong, T., Airey, D. C., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.047 · Cited by 123
Clinical Trials in Alzheimer’s Disease: A Hurdle in the Path of Remedy
Oxford, A. E., Stewart, E. S., & Rohn, T. T. (2020) · International Journal of Alzheimer's Disease · doi:10.1155/2020/5380346 · Cited by 107
Azzinnari, D., Sigrist, H., Staehli, S., Palme, R., Hildebrandt, T., Leparc, G., Hengerer, B., Seifritz, E., & Pryce, C. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.039 · Cited by 109
Quintana, D. S., Guastella, A. J., Westlye, L. T., & Andreassen, O. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.166 · Cited by 107
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Heilig, M. A., Augier, E., Pfarr, S., & Sommer, W. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0591-6 · Cited by 107
The microbiome as a novel paradigm in studying stress and mental health.
Liu, R. T. (2017) · American Psychologist · doi:10.1037/amp0000058 · Cited by 89
Revitalizing Psychiatric Therapeutics
Hyman, S. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.181 · Cited by 98
Self-citationOxytocin effects in schizophrenia: Reconciling mixed findings and moving forward
Bradley, E. R., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 89
Bishop, J. R., Zhang, L., & Lizano, P. L. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000321 · Cited by 100
Twenty-Five Years of Progress: The View from NIMH and NINDS
Insel, T. R., & Landis, S. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.041 · Cited by 85
Genome-scale neurogenetics: methodology and meaning
McCarroll, S. A., Feng, G., & Hyman, S. E. (2014) · Nature Neuroscience · doi:10.1038/nn.3716 · Cited by 87
Self-citationPostdependent state in rats as a model for medication development in alcoholism
Meinhardt, M. W., & Sommer, W. H. (2015) · Addiction Biology · doi:10.1111/adb.12187 · Cited by 83
Roberts, A. C., & Clarke, H. F. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902288116 · Cited by 79
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1567961 · Cited by 76
The current development of CNS drug research
Wegener, G., & Rujescu, D. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000345 · Cited by 73
The daunting polygenicity of mental illness: making a new map
Hyman, S. E. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0031 · Cited by 78
Self-citationNeuroscience and the future for mental health?
Rose, N. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000621 · Cited by 61
Animal Models in Translational Research: Rosetta Stone or Stumbling Block?
Bolker, J. A. (2017) · BioEssays · doi:10.1002/bies.201700089 · Cited by 75
Miller, A. H., & Raison, C. L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01887-y · Cited by 67
“found to be effective in psychotic and mood disorders, respectively [1, 2, 14].”
BackgroundInfluentialSoumier, A., Carter, R. M., Schoenfeld, T. J., & Cameron, H. A. (2016) · eneuro · doi:10.1523/eneuro.0116-15.2016 · Cited by 67
Organoid technology for brain and therapeutics research
Wang, Z., Wang, S., Xu, T., Miao, Z., Su, D., & Miao, C. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12754 · Cited by 65
Kentner, A. C., Cryan, J. F., & Brummelte, S. (2019) · Developmental Psychobiology · doi:10.1002/dev.21775 · Cited by 64
“While pharmacotherapies can be advantageous in the treatment of some neuropsychiatric disorders, they often have several limitations including the cost of development, accessibility, specificity and tolerability (Berk, 2012; Hyman, 2012; Munos, 2013).”
BackgroundLeDoux, J. E. (2020) · Current Biology · doi:10.1016/j.cub.2020.04.012 · Cited by 58
The “Vulnerability” of Psychiatric Research Participants
Bracken‐Roche, D., Bell, E. C., & Racine, É. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716633422 · Cited by 63
A role for 5-HT4 receptors in human learning and memory
Murphy, S. E., Wright, L. C., Browning, M. D., Cowen, P. J., & Harmer, C. J. (2019) · Psychological Medicine · doi:10.1017/s0033291719002836 · Cited by 80
Rigor or Mortis: Best Practices for Preclinical Research in Neuroscience
Steward, O., & Balice‐Gordon, R. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.042 · Cited by 63
Failed drug discovery in psychiatry: time for human genome-guided solutions
Papassotiropoulos, A., & de Quervain, D. J. ‐. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.02.002 · Cited by 64
Rediscovering the value of families for psychiatric genetics research
Glahn, D. C., Nimgaonkar, V. L., Raventós, H., Rojas, J. C., McIntosh, A. M., Thomson, P. A., Jablensky, A. V., McCarthy, N. S., Charlesworth, J., Blackburn, N. B., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0073-x · Cited by 64
Can prospective systematic reviews of animal studies improve clinical translation?
Pound, P., & Ritskes-Hoitinga, M. J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02205-x · Cited by 60
Changing the Mindset in Life Sciences Toward Translation: A Consensus
Duda, G. N., Grainger, D. W., Frisk, M. L., Bruckner‐Tuderman, L., Carr, A. J., Dirnagl, U., Einhäupl, K. M., Gottschalk, S. M., Gruskin, E. A., Huber, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0599 · Cited by 57
Suboptimal phenotypic reliability impedes reproducible human neurosciencePreprint
Nikolaidis, A., Chen, A. A., He, X., Shinohara, R. T., Vogelstein, J. T., Milham, M. P., & Shou, H. (2022) · Research Square · doi:10.1101/2022.07.22.501193 · Cited by 66
Zhou, J., Li, M., Wang, X., He, Y., Xia, Y., Sweeney, J. A., Kopp, R. F., Liu, C., & Chen, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.674273 · Cited by 56
Pathway Analyses Implicate Glial Cells in Schizophrenia
Duncan, L. E., Holmans, P., Lee, P. H., O'Dushlaine, C. T., Kirby, A. W., Smoller, J. W., Öngür, D., & Cohen, B. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089441 · Cited by 60
Mouse models of gene–environment interactions in schizophrenia
Kannan, G., Sawa, A., & Pletnikov, M. V. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.012 · Cited by 52
Post-translational protein modifications in schizophrenia
Mueller, T., & Meador‐Woodruff, J. H. (2020) · Schizophrenia · doi:10.1038/s41537-020-0093-9 · Cited by 57
Phenomenology and the Interpretation of Psychopathological Experience
Parnas, J., & Gallagher, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139424745.006 · Cited by 63
Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish
McCammon, J. M., & Sive, H. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019620 · Cited by 55
Translating the promise of 5HT4 receptor agonists for the treatment of depression
Murphy, S. E., de Cates, A. N., Gillespie, A. L., Godlewska, B. R., Scaife, J. C., Wright, L. C., Cowen, P. J., & Harmer, C. J. (2020) · Psychological Medicine · doi:10.1017/s0033291720000604 · Cited by 57
Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD)
Missig, G., McDougle, C. J., & Carlezon, W. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0409-5 · Cited by 53
Increasing diversity in genomics requires investment in equitable partnerships and capacity building
Martin, A. R., Stroud, R. E., Abebe, T., Akena, D. H., Alemayehu, M., Atwoli, L., Chapman, S. B., Flowers, K., Gelaye, B., Gichuru, S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01095-y · Cited by 50
Mental health: Depression needs large human-genetics studies
Hyman, S. (2014) · Nature · doi:10.1038/515189a · Cited by 46
Self-citationComputational perspectives on human fear and anxiety
Yamamori, Y., & Robinson, O. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104959 · Cited by 46
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
Pomrenze, M. B., Fetterly, T. L., Winder, D. G., & Messing, R. O. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13507 · Cited by 47
Circuit activity underlying a distinct modulator of prepulse inhibition
Heidinger, L., Reilly, J. L., Wang, L., & Goldman, M. B. (2019) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2019.04.005 · Cited by 45
The forced swim test has poor accuracy for identifying novel antidepressants
Trunnell, E. R., & Carvalho, C. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.003 · Cited by 52
The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research
Heilig, M. A., Sommer, W. H., & Spanagel, R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5006 · Cited by 47
Drug development in psychiatry: 50 years of failure and how to resuscitate it.
Nutt, D. (2025) · Lancet psychiatry · doi:10.1016/s2215-0366(24)00370-5 · Cited by 35
From hype to hope: Considerations in conducting robust microbiome science
McGuinness, A. J., Stinson, L. F., Snelson, M., Loughman, A., Stringer, A. M., Hannan, A. J., Cowan, C. S. M., Jama, H. A., Caparros-Martin, J. A., West, M. L., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.022 · Cited by 46
σ1 receptor ligands control a switch between passive and active threat responses
Rennekamp, A. J., Huang, X., Wang, Y., Patel, S., Lorello, P. J., Cade, L., Gonzales, A. P. W., Yeh, J.-R. J., Caldarone, B. J., Roth, B. L., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2089 · Cited by 52
Trunnell, E. R., Baines, J., Farghali, S., Jackson, T. A., Jayne, K., Smith, R., & Stibbe, T. (2024) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2024.105666 · Cited by 45
Carrillo‐Roa, T., Labermaier, C., Weber, P. C., Herzog, D. P., Lareau, C. A., Santarelli, S., Wagner, K. V., Rex‐Haffner, M., Harbich, D., Scharf, S. H., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002690 · Cited by 45
White Matter Injuries Induced by MK‐801 in a Mouse Model of Schizophrenia Based on NMDA Antagonism
Xiu, Y., Kong, X., Zhang, L., Qiu, X., Chao, F., Peng, C., Gao, Y., Huang, C., Wang, S., & Tang, Y. C. (2014) · The Anatomical Record · doi:10.1002/ar.22942 · Cited by 41
Gautam, V., Gaurav, A., Masand, N., Lee, V. S., & Patil, V. M. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10489-3 · Cited by 44
Huang, J., Liu, F., Tang, H., Wu, H., Li, L., Wu, R., Zhao, J., Wu, Y. H., Liu, Z., & Chen, J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00626 · Cited by 39
Haller, S. P., Stoddard, J., Botz-Zapp, C. A., Clayton, M., MacGillivray, C., Perhamus, G. R., Stiles, K., Kircanski, K., Penton‐Voak, I. S., Bar‐Haim, Y., et al. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.05.022 · Cited by 39
The Contribution of Environmental Enrichment to Phenotypic Variation in Mice and Rats.
Kentner, A. C., Speno, A. V., Doucette, J., & Roderick, R. C. (2021) · eneuro · doi:10.1523/eneuro.0539-20.2021 · Cited by 37
“…in a population and may undermine the robustness of the potential treatment being studied (Kentner et al., 2018; for excellent recent review, see Voelkl et al., 2020), a crucial concern given the disconnect between preclinical and clinical research outcomes (Berk, 2012; Hyman, 2012; Munos, 2013).”
BackgroundMedical Therapies for Children With Autism Spectrum Disorder—An Update
Edwin Williamson, M. D., Sathe, N. A., & Andrews, J. C. (2017) · doi:10.23970/ahrqepccer189 · Cited by 47
The Diminished Pipeline for Medications to Treat Mental Health and Substance Use Disorders
O’Brien, P. L., Parks, C. L., Hodgkin, D., Levit, K. R., & Mark, T. L. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201400044 · Cited by 37
Implicit aversive memory under anaesthesia in animal models: a narrative review
Samuel, N., Taub, A. H., Paz, R., & Raz, A. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.05.046 · Cited by 37
Preuss, T. M. (2019) · Brain Behavior and Evolution · doi:10.1159/000500500 · Cited by 36
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 43
The myelinated fiber loss in the corpus callosum of mouse model of schizophrenia induced by MK-801
Xiu, Y., Kong, X.-R., Zhang, L., Qiu, X., Gao, Y., Huang, C., Chao, F., Wang, S., & Tang, Y. C. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.013 · Cited by 36
Segev, A., Yanagi, M., Scott, D. E., Southcott, S. A., Lister, J. M., Tan, C., Li, W., Birnbaum, S. G., Kourrich, S., & Tamminga, C. A. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0124-3 · Cited by 35
Real-Time Functional MRI in the Treatment of Mental Health Disorders
Taschereau‐Dumouchel, V., Cushing, C. A., & Lau, H. C. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072220-014550 · Cited by 40
Xu, R., & Wang, Q. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.06.027 · Cited by 34
The unfulfilled promise of the antidepressant medications
Davey, C. G., & Chanen, A. M. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00194 · Cited by 31
Studying the Brain in a Dish: 3D Cell Culture Models of Human Brain Development and Disease
Brown, J. R., Quadrato, G., & Arlotta, P. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.03.002 · Cited by 36
Oña, G., Berrada, A., & Bouso, J. C. (2021) · Transcultural Psychiatry · doi:10.1177/13634615211038416 · Cited by 35
Haggarty, S. J., & Perlis, R. H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.028 · Cited by 32
Subjectivity and Schizophrenia: Another Look at Incomprehensibility and Treatment Nonadherence
Parnas, J., & Henriksen, M. G. (2013) · Psychopathology · doi:10.1159/000351837 · Cited by 37
Metadata
- Authors
- Hyman, S. E.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Hyman, Steven E.
- ORCID
- Hyman, Steven E.
- Venue
- Science Translational Medicine
- Published
- 2012-10-10
- Volume
- 4
- Issue
- 155
- Pages
- 155cm11-155cm11
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4250451153
- Cited by
- 260
- References
- 28
- Citations by year
- 2026: 17 · 2025: 10 · 2024: 20 · 2023: 13 · 2022: 19 · 2021: 24 · 2020: 16 · 2019: 25 · 2018: 19 · 2017: 15 · 2016: 22 · 2015: 25 · 2014: 16 · 2013: 16 · 2012: 3
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- drug discovery, mental illness, schizophrenia, bipolar disorder, depression, autism spectrum disorder, pharmaceutical industry, unmet medical needs
- MeSH terms
- Autistic Disorder, Bipolar Disorder, Pharmaceutical Preparations, Humans, Schizophrenia, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.